IP Library › Granted Patent US 11,937,922
Granted Patent B2
US 11,937,922 · App. 17/288,380 · Granted Mar 26, 2024

pH-triggered diagnostic wound dressing

Inventors: Markus Kettel (Heidenheim, DE); Andrew Tobias Jenkins (Bath, GB); Laura Wallace (Bath, GB)
Assignee: PAUL HARTMANN AG
A61B5/14539A61B5/6802A61K49/0069A61L26/0019A61L26/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,937,922
App. No.
17/288,380
Granted
Mar 26, 2024
Kind
B2
Abstract

The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.

Claims (24)

1. A wound dressing comprising:

a) a hydrogel layer able to be orientated facing towards the wound,

b) a layer comprising a pH-sensitive polymer, and

c) one or more compartment(s) comprising carrier containing fluorescent dye,

wherein each compartment c) is placed in layer b), and

wherein layer b) comprises one or more recesses opposite the wound, wherein in said one or more recesses the one or more compartment(s) c) are embedded.

2. The wound dressing according to claim 1 , wherein the hydrogel is a polyurethane-based hydrogel.

3. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at a pH value of 4 is less than at a pH value of 8.

4. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 6 is less than 0.1 mg/min/g.

5. The wound dressing according to claim 4 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 8 is more than 1 mg/min/g.

6. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 8 is more than 1 mg/min/g.

7. The wound dressing according to claim 1 , wherein the pH-sensitive polymer is a (methyl acrylate-methyl methacrylate-methacrylic acid) copolymer.

8. The wound dressing according to claim 1 , wherein layer b) further comprises a plasticizer.

9. The wound dressing according to claim 1 , wherein the carrier is of the same material as the hydrogel or the pH-sensitive polymer.

10. The wound dressing according to claim 1 , wherein the carrier is a polymer selected from polyethylene glycol, polypropylene glycol, polyethylene-polypropylene glycol copolymer, polyvinyl alcohol, polyvinylpyrrolidone, methylcellulose, hydroxypropyl methylcellulose and mixtures thereof.

11. The wound dressing according to claim 1 , wherein the carrier is polyvinyl alcohol.

12. The wound dressing according to claim 1 , wherein the fluorescent dye belongs to the group of xanthenes bearing at least one hydroxy group.

13. The wound dressing according to claim 1 , wherein the fluorescent dye is fluorescein or carboxy fluorescein.

14. The wound dressing according to claim 1 , wherein the carrier contains a buffer and/or one or more therapeutic substance(s).

15. A method of treating a wound comprising the step of applying a wound dressing to the wound, wherein said wound dressing comprises:

a) a hydrogel layer able to be orientated facing towards the wound,

b) a layer comprising a pH-sensitive polymer, and

c) one or more compartments comprising a carrier containing fluorescent dye,

wherein each of the one or more compartments c) is placed in layer b), wherein layer b) comprises one or more recesses opposite the wound, wherein in said one or more recesses the one or more compartments c) comprising the carrier containing fluorescent dye are embedded as an infection indicator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: JENKINS, ANDREW TOBIAS; WALLACE, LAURA; KETTEL, MARKUS
To: PAUL HARTMANN AG
Reel/Frame 057334/0178 →
Priority Claims (1)
EP 18202424 · Oct 24, 2018 · regional
Continuity (1)
Related Publication 20210378565A1 · Dec 9, 2021